Related Experiment Videos
The control of hyperphosphataemia in haemodialysis patients
L Papayianni1, K Katopodis, J Kosmanou
1Nurse of Renal Unit, University Hospital of Ioannina, Greece.
EDTNA/ERCA Journal (English Ed.)
|July 15, 1998
Abstract:
Patients with chronic uraemia develop various metabolic abnormalities, the most significant being the low production of vitamin D [1.25(OH)2D3] by the kidneys (1-3), hyperphosphataemia, and hypocalcaemia (4). These abnormalities, occurring usually in combination, are responsible for the pathogenesis of secondary hyperparathyroidism (HPT) (5-11). Prevention and treatment of secondary HPT can be achieved by means of administration of vitamin D and calcium. However, the above treatment is conditional on a low serum phosphorus concentration.